Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Bevcanna Enterprises Inc C.BEV

Alternate Symbol(s):  BVNNF

BevCanna Enterprises Inc. is a diversified lifestyle and wellness consumer packaged goods company. The Company operates through three segments: non-cannabis beverage, cannabis beverage and eCommerce. The non-cannabis beverage segment consists of alkaline and mineralized beverages, which include the development and manufacturing of TRACE brand and other beverages and supplements. The cannabis... see more

CSE:BEV - Post Discussion

Bevcanna Enterprises Inc > Capital Structure and 3 year forecast
View:
Post by gardy on Sep 18, 2021 10:21pm

Capital Structure and 3 year forecast

So dated Sept 6 2019 was their Stable Capital Structure of shares issued and outstanding of 46,015,857. Options of 1,250,000 Dec 14 2023 and warrants of 4,000,000 Feb 2023. For a total of 51,265,857 shares fully diluted and outstanding. Low and behold as of today there are 176,920,000 outstanding. 
As for their 3 year revenue forecast: year 2020 - $11,851,646 - Year 2021 - $ 20,711,259 
Year - 2022 - $ 37,288,393. Forecast excludes opportuniities at the LOI stage: Outdoor cultivation joint venture and launching 2 US complemetary brand joint ventures in Canada. Also excludes the national US rollout of a Hemp CBD infused plant based beverage which is waiting FDA approval. 

So in 2 years they have over tripled the outstanding shares and how many of these forecasts have they hit. ( would you like a hint.) 

I do not own this stock and never will as I was unfortunately involved with RYU. Still trying to minimize my losses there. This is the same BS story that has already been spun before. 

Just Sayin
Gardy
Comment by luckyAF on Sep 20, 2021 12:14am
yep. failure after failure operationally. all the while dilution enriching insiders. Talk is cheap. This company has run out of chances to say "trust us we'll meet projections this time".
Comment by xxxxxx on Sep 20, 2021 2:01am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities